Literature DB >> 22874415

Activation of α7 nicotinic receptors by orthosteric and allosteric agonists: influence on single-channel kinetics and conductance.

Magda M Pałczyńska1, Marie Jindrichova, Alasdair J Gibb, Neil S Millar.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) are oligomeric transmembrane proteins in which five subunits coassemble to form a central ion channel pore. Conventional agonists, such as acetylcholine (ACh), bind to an orthosteric site, located at subunit interfaces in the extracellular domain. More recently, it has been demonstrated that nAChRs can also be activated by ligands binding to an allosteric transmembrane site. In the case of α7 nAChRs, ACh causes rapid activation and almost complete desensitization. In contrast, allosteric agonists such as 4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c] quin oline-8-sulfonamide (4BP-TQS) activate α7 nAChRs more slowly and cause only low levels of apparent desensitization. In the present study, single-channel patch-clamp recording has been used to investigate differences in the mechanism of activation of α7 nAChRs by ACh and 4BP-TQS. The most striking difference between activation by ACh and 4BP-TQS is in single-channel kinetics. In comparison with activation by ACh, single-channel open times and burst lengths are substantially longer (~160-800-fold, respectively), and shut times are shorter (~8-fold) when activated by 4BP-TQS. In addition, coapplication of ACh and 4BP-TQS results in a further increase in single-channel burst lengths. Mean burst lengths seen when the two agonists are coapplied (3099 ± 754 ms) are ~2.5-fold longer than with 4BP-TQS alone and ∼370-fold longer than with ACh alone. Intriguingly, the main single-channel conductance of α7 nAChRs, was significantly larger when activated by 4BP-TQS (100.3 ± 2.4 pS) than when activated by ACh (90.0 ± 2.7 pS), providing evidence that activation by allosteric and orthosteric agonists results in different α7 nAChRs open-channel conformations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22874415      PMCID: PMC3477227          DOI: 10.1124/mol.112.080259

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  36 in total

1.  The single-channel properties of human acetylcholine alpha 7 receptors are altered by fusing alpha 7 to the green fluorescent protein.

Authors:  Sergio Fucile; Eleonora Palma; Ataulfo Martinez-Torres; Ricardo Miledi; Fabrizio Eusebi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 2.  The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences.

Authors:  Nicolas Le Novère; Pierre-Jean Corringer; Jean-Pierre Changeux
Journal:  J Neurobiol       Date:  2002-12

3.  Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function.

Authors:  Qiang Nai; J Michael McIntosh; Joseph F Margiotta
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

Review 4.  Cys-loop receptors: new twists and turns.

Authors:  Henry A Lester; Mohammed I Dibas; David S Dahan; John F Leite; Dennis A Dougherty
Journal:  Trends Neurosci       Date:  2004-06       Impact factor: 13.837

5.  Voltage dependence and stability of the gating kinetics of the fast chloride channel from rat skeletal muscle.

Authors:  D S Weiss; K L Magleby
Journal:  J Physiol       Date:  1990-07       Impact factor: 5.182

6.  A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX.

Authors:  S Couturier; D Bertrand; J M Matter; M C Hernandez; S Bertrand; N Millar; S Valera; T Barkas; M Ballivet
Journal:  Neuron       Date:  1990-12       Impact factor: 17.173

7.  Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

8.  Properties of neuronal alpha7 mutant nicotinic acetylcholine receptors gated by bicuculline.

Authors:  Raffaella Tonini; E Palma; R Miledi; F Eusebi
Journal:  Neuropharmacology       Date:  2003-05       Impact factor: 5.250

9.  On the stochastic properties of bursts of single ion channel openings and of clusters of bursts.

Authors:  D Colquhoun; A G Hawkes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1982-12-24       Impact factor: 6.237

10.  A series of α7 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties.

Authors:  JasKiran K Gill; Persis Dhankher; Tom D Sheppard; Emanuele Sher; Neil S Millar
Journal:  Mol Pharmacol       Date:  2012-02-10       Impact factor: 4.436

View more
  10 in total

Review 1.  Nicotinic acetylcholine receptors at the single-channel level.

Authors:  Cecilia Bouzat; Steven M Sine
Journal:  Br J Pharmacol       Date:  2017-04-08       Impact factor: 8.739

2.  Macroscopic and Microscopic Activation of α7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107.

Authors:  Marta Quadri; Sumanta Garai; Ganesh A Thakur; Clare Stokes; Alican Gulsevin; Nicole A Horenstein; Roger L Papke
Journal:  Mol Pharmacol       Date:  2018-10-22       Impact factor: 4.436

Review 3.  Molecular function of α7 nicotinic receptors as drug targets.

Authors:  Cecilia Bouzat; Matías Lasala; Beatriz Elizabeth Nielsen; Jeremías Corradi; María Del Carmen Esandi
Journal:  J Physiol       Date:  2017-11-29       Impact factor: 5.182

4.  Molecular function of the novel α7β2 nicotinic receptor.

Authors:  Beatriz E Nielsen; Teresa Minguez; Isabel Bermudez; Cecilia Bouzat
Journal:  Cell Mol Life Sci       Date:  2018-01-08       Impact factor: 9.261

5.  An Unaltered Orthosteric Site and a Network of Long-Range Allosteric Interactions for PNU-120596 in α7 Nicotinic Acetylcholine Receptors.

Authors:  Christopher B Marotta; Henry A Lester; Dennis A Dougherty
Journal:  Chem Biol       Date:  2015-07-23

6.  Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites.

Authors:  Xiang-Qun Hu
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

7.  Pharmacological Characterisation of Nicotinic Acetylcholine Receptors Expressed in Human iPSC-Derived Neurons.

Authors:  Anna Chatzidaki; Antoine Fouillet; Jingling Li; Jeffrey Dage; Neil S Millar; Emanuele Sher; Daniel Ursu
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

8.  TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors.

Authors:  Teagan R Wall; Brandon J Henderson; George Voren; Charles R Wageman; Purnima Deshpande; Bruce N Cohen; Sharon R Grady; Michael J Marks; Daniel Yohannes; Paul J Kenny; Merouane Bencherif; Henry A Lester
Journal:  Front Pharmacol       Date:  2017-09-26       Impact factor: 5.810

9.  Contrasting properties of α7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors.

Authors:  JasKiran K Gill; Anna Chatzidaki; Daniel Ursu; Emanuele Sher; Neil S Millar
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

Review 10.  Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.

Authors:  Roger L Papke; Nicole A Horenstein
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.